000504 Stock Overview
Operates as a biomedical technology company. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Landfar Bio-medicine Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥9.35 |
52 Week High | CN¥11.39 |
52 Week Low | CN¥6.05 |
Beta | 0.72 |
1 Month Change | 4.00% |
3 Month Change | -7.15% |
1 Year Change | 11.05% |
3 Year Change | -40.97% |
5 Year Change | 29.14% |
Change since IPO | 388.20% |
Recent News & Updates
Some Landfar Bio-medicine Co., Ltd (SZSE:000504) Shareholders Look For Exit As Shares Take 26% Pounding
Jan 03There's Reason For Concern Over Landfar Bio-medicine Co., Ltd's (SZSE:000504) Massive 37% Price Jump
Oct 21Recent updates
Some Landfar Bio-medicine Co., Ltd (SZSE:000504) Shareholders Look For Exit As Shares Take 26% Pounding
Jan 03There's Reason For Concern Over Landfar Bio-medicine Co., Ltd's (SZSE:000504) Massive 37% Price Jump
Oct 21Risks Still Elevated At These Prices As Landfar Bio-medicine Co., Ltd (SZSE:000504) Shares Dive 31%
Jun 09Landfar Bio-medicine Co., Ltd's (SZSE:000504) Popularity With Investors Under Threat As Stock Sinks 32%
Apr 17Landfar Bio-medicine Co., Ltd (SZSE:000504) Investors Are Less Pessimistic Than Expected
Mar 01Shareholder Returns
000504 | CN Biotechs | CN Market | |
---|---|---|---|
7D | -0.7% | 4.1% | 1.3% |
1Y | 11.0% | -9.7% | 16.8% |
Return vs Industry: 000504 exceeded the CN Biotechs industry which returned -10.4% over the past year.
Return vs Market: 000504 underperformed the CN Market which returned 17.3% over the past year.
Price Volatility
000504 volatility | |
---|---|
000504 Average Weekly Movement | 6.4% |
Biotechs Industry Average Movement | 5.2% |
Market Average Movement | 6.3% |
10% most volatile stocks in CN Market | 10.4% |
10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 000504 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000504's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1991 | n/a | Changqiao You | www.landfar.cn |
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. The company operates through Biomedicine, and Energy Saving and Environmental Protection segments. The Biomedicine segment engages in the provision of stem cell storage and technical services; stem cell therapy research; medical device procurement and sales, etc. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business.
Landfar Bio-medicine Co., Ltd Fundamentals Summary
000504 fundamental statistics | |
---|---|
Market cap | CN¥3.09b |
Earnings (TTM) | -CN¥37.07m |
Revenue (TTM) | CN¥124.45m |
24.8x
P/S Ratio-83.2x
P/E RatioIs 000504 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
000504 income statement (TTM) | |
---|---|
Revenue | CN¥124.45m |
Cost of Revenue | CN¥40.02m |
Gross Profit | CN¥84.43m |
Other Expenses | CN¥121.50m |
Earnings | -CN¥37.07m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 29, 2025
Earnings per share (EPS) | -0.11 |
Gross Margin | 67.84% |
Net Profit Margin | -29.79% |
Debt/Equity Ratio | 4.4% |
How did 000504 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/20 02:40 |
End of Day Share Price | 2025/02/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Landfar Bio-medicine Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.